Skip to main navigation Skip to search Skip to main content

High rates of clinical and subclinical tuberculosis among HIV-infected ambulatory subjects in Tanzania

  • Lillian Mtei
  • , Mecky Matee
  • , Oliver Herfort
  • , Muhammad Bakari
  • , C. Robert Horsburgh
  • , Richard Waddell
  • , Bernard F. Cole
  • , Jenni M. Vuola
  • , Susan Tvaroha
  • , Barry Kreiswirth
  • , Kisali Pallangyo
  • , C. Fordham Von Reyn
  • Muhimbili University of Health and Allied Sciences
  • Dartmouth College
  • Boston University
  • National Institute for Health and Welfare
  • GlaxoSmithKline

Research output: Contribution to journal › Article › peer-review

185 Scopus citations

Abstract

Background. We sought to determine the prevalence of active tuberculosis among ambulatory HIV-infected persons in Tanzania with CD4 cell counts of ≥200 cells/mm3 and a bacille Calmette-Guérin vaccination scar. Methods. Subjects who volunteered for a tuberculosis booster vaccine trial were screened for active tuberculosis by obtainment of a history, physical examination, chest radiography, sputum culture and acid fast bacillus (AFB) stain, and blood culture. All subjects underwent a tuberculin skin test (TST) and lymphocyte proliferation assays (LPAs) for detection of responses to mycobacterial antigens. Results. Active tuberculosis was identified at baseline in 14 (15%) of the first 93 subjects who were enrolled: 10 (71%) had clinical tuberculosis (symptoms or chest radiograph findings), and 4 (29%) had subclinical tuberculosis (positive sputum AFB stain or culture results but no symptoms or chest radiograph findings). An additional 6 subjects with subclinical tuberculosis were identified subsequently. The 10 subjects with subclinical tuberculosis included 3 with positive sputum AFB stains results and 7 who were only identified by a positive sputum culture result. Compared with subjects who did not have tuberculosis, the 10 subjects with subclinical tuberculosis were more likely to have peripheral lymphadenopathy, positive TST results, and elevated LPA responses to early secreted antigenic target-6 (ESAT). Eight of 10 patients had received isoniazid because of a positive TST result before active tuberculosis was recognized. Conclusions. Clinical and subclinical tuberculosis are common among ambulatory HIV-infected persons, and some cases can only be identified by sputum culture. World Health Organization guidelines for screening for latent tuberculosis before treatment do not recommend sputum culture and, therefore, may fail to identify a substantial number of HIV-infected persons with subclinical, active tuberculosis.

Original languageEnglish
Pages (from-to)1500-1507
Number of pages8
JournalClinical Infectious Diseases
Volume40
Issue number10
DOIs
StatePublished - 15 May 2005

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'High rates of clinical and subclinical tuberculosis among HIV-infected ambulatory subjects in Tanzania'. Together they form a unique fingerprint.

Cite this